Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
FENC

Fennec

$9.37

0.33 (3.65%)

06:22
08/07/18
08/07
06:22
08/07/18
06:22
Hot Stocks
Fennec: PDCO accepts pediatric investigation plan for PEDMARK »

Fennec Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FENC

Fennec

$9.60

-0.29 (-2.93%)

04:55
07/12/18
07/12
04:55
07/12/18
04:55
Conference/Events
Fennec management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jul

FENC

Fennec

$10.10

-0.23 (-2.23%)

15:05
07/09/18
07/09
15:05
07/09/18
15:05
Conference/Events
Fennec management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jul

Over a quarter ago
FENC

Fennec

$10.97

0.5 (4.78%)

16:34
06/22/18
06/22
16:34
06/22/18
16:34
Hot Stocks
Breaking Hot Stocks news story on Fennec »

Opaleye Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FENC

Fennec

$10.94

-0.03 (-0.27%)

06:06
06/21/18
06/21
06:06
06/21/18
06:06
Hot Stocks
Fennec's Pedmark for ototoxicity meets primary endpoint in phase 3 study »

Fennec announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FENC

Fennec

$10.84

-0.06 (-0.55%)

06:05
06/11/18
06/11
06:05
06/11/18
06:05
Hot Stocks
Fennec set to join Russell 3000 Index »

Fennec announced it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FENC

Fennec

$11.10

0.06 (0.54%)

, VERI

Veritone

$20.64

0.43 (2.13%)

08:30
05/29/18
05/29
08:30
05/29/18
08:30
Options
Four new option listings and three option delistings on May 29th »

New option listings for…

FENC

Fennec

$11.10

0.06 (0.54%)

VERI

Veritone

$20.64

0.43 (2.13%)

HDNG

Hardinge

$18.50

0.005 (0.03%)

OAKS

Five Oaks

$0.00

(0.00%)

RSO

Resource Capital

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 30

    May

  • 05

    Jun

RHT

Red Hat

$153.09

5.19 (3.51%)

, GSK

GlaxoSmithKline

$37.43

0.01 (0.03%)

09:08
03/27/18
03/27
09:08
03/27/18
09:08
Hot Stocks
On The Fly: Pre-market Movers »

HIGHER: GlaxoSmithKline…

RHT

Red Hat

$153.09

5.19 (3.51%)

GSK

GlaxoSmithKline

$37.43

0.01 (0.03%)

NVS

Novartis

$79.68

1.12 (1.43%)

ESPR

Esperion

$71.79

1.62 (2.31%)

NSPR

InspireMD

$2.04

-0.13 (-5.99%)

FRAN

Francesca's

$4.80

0.13 (2.78%)

FENC

Fennec

$10.90

-0.04 (-0.37%)

OSTK

Overstock.com

$44.60

-0.6 (-1.33%)

GERN

Geron

$5.98

0.34 (6.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 27

    Mar

  • 27

    Mar

  • 27

    Mar

  • 28

    Mar

  • 03

    Apr

  • 04

    Apr

  • 11

    Apr

  • 23

    Apr

  • 17

    May

  • 29

    Mar

FENC

Fennec

$10.90

-0.04 (-0.37%)

08:11
03/27/18
03/27
08:11
03/27/18
08:11
Hot Stocks
Fennec up 17% after FDA grants Breakthrough Therapy designation for PEDMARK »

In pre-market trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FENC

Fennec

$10.90

-0.04 (-0.37%)

06:31
03/27/18
03/27
06:31
03/27/18
06:31
Hot Stocks
Fennec: FDA grants Breakthrough Therapy designation for PEDMARK »

Fennec Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.